Market Trading Guide: Emcure Pharma among 2 stock recommendations for Monday
1/3
Stock Ideas
Indian equities witnessed a relief rally on Friday as concerns over an imminent US Fed rate hike eased. However, gains remained capped due to profit booking at higher levels and persistent geopolitical tensions in the Middle East. Analysts say strong earnings momentum, resilient economic growth, and robust domestic demand continue to underpin investor confidence in the broader market.
Here are two stock recommendations for Monday
Here are two stock recommendations for Monday
2/3
Wockhardt - Buy
Buying Zone: 2088-2099 | Stop-loss: Rs 2000 | Target: Rs 2260
Wockhardt Limited has staged a clear horizontal resistance breakout above 2,040 on the daily chart with a strong bullish candle (+7.08%). Backed by key short-term EMAs, expanding trade volume, and an RSI turning sharply upward toward 65, the structure signals strong upside momentum toward higher levels.
Virat Jagad, Sr Technical Research Analyst, at Bonanza Portfolio
Wockhardt Limited has staged a clear horizontal resistance breakout above 2,040 on the daily chart with a strong bullish candle (+7.08%). Backed by key short-term EMAs, expanding trade volume, and an RSI turning sharply upward toward 65, the structure signals strong upside momentum toward higher levels.
Virat Jagad, Sr Technical Research Analyst, at Bonanza Portfolio
3/3
Emcure Pharma - Buy
Buying Zone: 1927-1935 | Stop-loss: Rs 1870 | Target: Rs 2050
Emcure Pharmaceuticals Limited has bounced sharply off its 20-day EMA support around 1,870 on the daily chart. Supported by sustained alignment above long-term moving averages, an expanding daily volume bar, and a quick RSI reversal from 40 toward 60, the setup points to a strong continuation rally toward previous peak resistance.
Virat Jagad, Sr Technical Research Analyst, at Bonanza Portfolio
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
Emcure Pharmaceuticals Limited has bounced sharply off its 20-day EMA support around 1,870 on the daily chart. Supported by sustained alignment above long-term moving averages, an expanding daily volume bar, and a quick RSI reversal from 40 toward 60, the setup points to a strong continuation rally toward previous peak resistance.
Virat Jagad, Sr Technical Research Analyst, at Bonanza Portfolio
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)